Insulin aspart, recombinant Subcutaneous and Methylene blue injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Methylene blue injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: methylene blue
Brand name: ProvayBlue, Urolene Blue
Synonyms: Methylene blue (injection), Methylene Blue
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Methylene blue Oral, Intravenous
- Insulin aspart, recombinant Subcutaneous-Methylergonovine
- Insulin aspart, recombinant Subcutaneous-Methylergonovine Injection
- Insulin aspart, recombinant Subcutaneous-Methylergonovine Maleate Injection
- Insulin aspart, recombinant Subcutaneous-Methylergonovine Maleate Tablets
- Insulin aspart, recombinant Subcutaneous-Methylergonovine oral and injection
- Methylene blue injection-Insulin degludec
- Methylene blue injection-Insulin Degludec (U-100) Prefilled Pens
- Methylene blue injection-Insulin Degludec (U-100) Vials
- Methylene blue injection-Insulin Degludec (U-200) Prefilled Pens
- Methylene blue injection-Insulin degludec and liraglutide
- Methylene blue injection-Insulin degludec and liraglutide Subcutaneous